Co. Produces Record Amount at Mexico Mine
Source: Oliver O’Donnell 03/03/2025
Now operating at commercial rates and accessing higher grade, this miner is poised to deliver profitability in the near term, noted a VSA Capital Markets report.
Sierra Madre Gold and Silver Ltd. (SM:TSX.V; SMDRF:OTCQX) achieved full commercial and record production in January at its La Guitarra silver-gold project in Mexico, reported VSA Capital Markets Analyst Oliver O’Donnell in a Feb. 24 research note.
“With the company now consistently achieving throughput at commercial run rates and accessing higher grade material, this provides the platform to deliver profitability over the coming quarters,” O’Donnell wrote. “This will provide the necessary catalysts, in our view, for a rerating and outperformance against the sector.”
120% Return Potential
Sierra Madre’s share price is now about CA$0.59, having increased 37.2% since early December 2024, and noted O’Donnell, VSA Capital expects it to move higher.
Its price target on the Canadian producer is CA$1.30 per share, which implies further upside of 120%.
“We expect that positive operating and financial results over the coming months will provide the catalysts to break out [of the recent trading range] to the upside while the backdrop for gold and silver remain positive,” the analyst wrote.
Sierra Madre remains a Buy.
Past Production Milestones
O’Donnell recapped Sierra Madre’s production achievements to date. The company started commercial production at La Guitarra on July 1, 2024 and reached industrial production in December. All told last year, Sierra Madre delivered 1,292.5 dry metric tons (dmt) of concentrate, equal to about 108,000 ounces (108 Koz) of silver and 1.452 Koz of gold based on reported grades of 2,594.2 grams per ton (2,594.2 g/t) silver and 34.93 g/t gold.
In January the company reached full commercial production and set a production record. It shipped 349.48 dmt of concentrate and had 45.81 dmt left in inventory.
“The latest monthly production record demonstrates the results of the successful debottlenecking of the plant and development improvements underground,” wrote O’Donnell. “The newly opened underground operating faces, some of which are outside the current compliant resources limits, should provide higher grade material to the mill more consistently.”
With these grade improvements, purported O’Donnell, the miner should be able to reach its production target of 350 dmt per month and simultaneously enhance margins.
Financial Expectations
Accordingly, VSA expects Sierra Madre’s upcoming production and earnings updates to show operational consistency, and increased revenue and profit, noted O’Donnell. VSA anticipates Sierra Madre’s full-year 2024 revenue to be US$7 million (US$7M). In Q3/24, the period ended Sept. 30, 2024, the company generated US$2.5M and achieved an operating profit of US$0.25M.
As for this year, VSA revised its expectations for Sierra Madre to reflect its recent “better-than-expected performance in terms of optimizing recoveries” and the rapid ascent of the silver and gold prices to US$30 and US$3,000 per ounce, respectively.
“Our current 2025F indication is for about 400 Koz silver and 4.7 Koz gold, indicating revenue of US$25M and EBITDA of US$10M based on consistent operations at around 500 tons per day (500 tpd) throughput,” O’Donnell wrote.
Sierra Madre should generate enough cash flow to cover the cost of doubling throughput to 1,000 tpd as it would require additional equipment. Previously, management indicated that by 24 months from the start of production at La Guitarra, they would have enough information for an expansion decision.
Ownership and Share Structure
O’Donnell pointed out that Sierra Madre’s major shareholders are First Majestic Silver Corp. (FR:TSX; AG:NYSE; FMV:FSE) with 44.9%, Commodity Capital AG with 4.4% and Sierra Madre President and Chief Executive Officer Alex Langer with 2.7%.
The precious metals producer has 153.9 million shares in issue and a market cap of CA$91.2M.
Sign up for our FREE newsletter at: www.streetwisereports.com/get-news
Important Disclosures:
- Sierra Madre Gold and Silver Ltd. is a billboard sponsor of Streetwise Reports and pays SWR a monthly sponsorship fee between US$4,000 and US$5,000.
- Doresa Banning wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an independent contractor.
- This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.
For additional disclosures, please click here.
Disclosures for VSA Capital, Sierra Madre Gold and Silver Ltd., February 24, 2025
Investment Analyst Certification In my role as a Research Analyst for VSA Capital Limited, I hereby certify that the views about the companies and their securities discussed in this report are accurately expressed and that I have not received and will not receive direct or indirect compensation in exchange for expressing specific recommendations or views in this report. Non-Independent Research This is a marketing communication. It is non-independent research as it has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. Important Disclosures This research report has been prepared by VSA Capital Limited, which is party to an agreement to be paid a fee as corporate finance advisors and arrangers with, or has provided investment banking services to, Sierra Madre, or has been party to such an agreement within the last twelve months, and is solely for, and directed at, persons who are Professional Clients as defined under Annex II of the Markets in Financial Instruments Directive, Directive 2004/39/EC, or as defined in the FCA Handbook. Persons who do not fall within the above category should return this research report to VSA Capital Limited, Park House, 16-18 Finsbury Circus, London EC2M 7EB, immediately. VSA Capital may distribute research in reliance on Rule 15a-6(a)(2) of the Securities and Exchange Act 1934 to persons that are major US Institutional investors, however, transactions in any securities must be effected through a US registered broker-dealer. If you are a US person, you must fulfil the requirements of a major US institutional investor as defined by the Securities Exchange Act 1934 and subsequent guidance from the SEC to receive this research report. Any failure to comply with this restriction may constitute a violation of US law for which VSA Capital Limited does not accept responsibility. The information in this report is not intended to be published or made available to any person in any jurisdiction where to d o so would result in contravention of any applicable laws or regulations. Accordingly, if it is prohibited to make such information available in your jurisdiction or to you (by reason of your nationality, residence or otherwise) it is not directed at you. This research report is not intended to be distributed or passed on, directly or indirectly, to any other class of persons. It is being supplied to you solely for your information and may not be reproduced, forwarded to any other person or published, in whole or in part, for any purpose, without out prior written consent. Neither the information nor any opinion expressed constitutes an offer, or an invitation to make an offer, to buy or sell any securities or any options, futures or other derivatives related to such securities. The information and opinions contained in this research report have been compiled or arrived at by VSA Capital Limited from s ources believed to be reliable and in good faith but no representation or warranty, express or implied, is made as to their accurac y, completeness or correctness. All opinions and estimates contained in the research report constitute the Company’s judgments as of the date of the report and are subjec t to change without notice. The information contained in the report is published for the assistance of those persons defined above but it is not to be relied upon as authoritative or taken in substitution for the exercise of the judgment of any reader. The Company accepts no liability whatsoever for any direct or consequential loss arising from any use of the information cont ained herein. The company does not make any representation to any reader of the research report as to the suitability of any investment made in connection with this report and readers must satisfy themselves of the suitability in light of their own understanding, appraisal of risk and rewa rd, objectives, experience and financial and operational resources. The value of any companies or securities referred to in this research report may rise as well as fall and sums recovered may be less than those originally invested. Any references to past performance of any companies or investments referred to in this research report are not indicative of their future performance. The Company and/or its directors and/or employees may have long or short positions in the securities mentioned herein, or in options, futures and other derivative instruments based on these securities or commodities. Not all of the products recommended or discussed in this research report may be regulated by the Financial Services and Marke ts Act 2000, as amended by The Financial Services and Markets Act 2012, and the rules made for the protection of investors by that Act will not apply to them. If you are in any doubt about the investment to which this report relates, you should consult a person authorised and regulated by t he Financial Conduct Authority who specialises in advising on securities of the kind described. The Company does and seeks to do business with the companies covered in its research reports. Thus, investors should be aware that the Company may have a conflict of interest that may affect the objectivity of this report. To view our policy on conflicts of interest and connected companies, please go to: http://www.vsacapital.com/policies/conflict-of-interest-policy. VSA Capital acts as Corporate Adviser/Broker to Sierra Madre and is therefore classed as a connected company. Investors should consider this report as only a single factor in making their investment decision. Definition of Ratings VSA Capital Limited uses the following stock rating system to describe its equity recommendations. Investors should carefully read the definitions of all ratings used in each research report. In addition, since the research report contains more complete information concerning the analyst’s views investors should carefully read the entire research report and not infer its contents from the rating alone. In any case, ratings (or research) should not be used or relied upon as investment advice. An investor’s decision to buy or sell a stock or investment fund should depend on individual circumstances and other considerations. VSA Capital imited’s recommendations are defined as follows: BUY: The stock is expected to increase by in excess of 10% in absolute terms over the next twelve months. HOLD: The price of the stock is expected to move in a range between -10% and +10% in absolute terms over the next twelve months. SELL: The stock is expected to decrease by in excess of 10% in absolute terms over the next twelve months. VSA Capital Limited is Authorised and Regulated by the Financial Conduct Authority © VSA Capital Limited, 2025, all rights reserved Park House, 16-18 Finsbury Circus, London EC2M 7EB | +44 (0)20 3005 5000 | www.vsacapital.com Registered in England: No. 02405923 VSA Capital Limited is a member of the London Stock Exchange. In addition, on occasion, if the stock has the potential to increase by in excess of 10%, but on qualitative grounds rather t han quantitative, a SPECULATIVE BUY may be used. Distribution of VSA Capital Limited’s Equities Recommendations VSA Capital Limited must disclose in each research report the percentage of all securities rated by the member to which the m ember would assign a “B Y” “ or “S ” rating and also the proportion of relevant investments in each category issued by the issuers to which the firm supplied investment banking services during the previous twelve months. The said ratings are updated on a quarterly basis.
( Companies Mentioned: SM:TSX.V; SMDRF:OTCQX, )
Source: https://www.streetwisereports.com/article/2025/03/03/co-produces-record-amount-at-mexico-mine.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
